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Background: Noroviruses (NoV) are the leading cause of viral gastroenteritis worldwide. Recombination frequently
occurs within and between NoV genotypes and recombinants have been implicated in sporadic cases, outbreaks
and pandemics of NoV. There is a lack of data on NoV recombinants in Africa and therefore their presence and
diversity was investigated in South Africa (SA).
Results: Between 2010 and 2013, eleven types of NoV recombinants were identified in SA. Amplification of the
polymerase/capsid region spanning the ORF1/2 junction and phylogenetic analysis confirmed each of the
recombinant types. SimPlot and maximum x2 analysis indicated that all recombinants had a breakpoint in the
region of the ORF1/2 junction (P < 0.05). The majority (9/11) were intergenotype recombinants, but two
intragenotype GII.4 recombinants were characterised. Three combinations represent novel recombinants namely GII.
P not assigned (NA)/GII.3, GII.P4 New Orleans 2009/GII.4 NA and GII.P16/GII.17. Several widely reported recombinants
were identified and included GII.P21/GII.2, GII.P21/GII.3, GII.Pe/GII.4 Sydney 2012, and GII.Pg/GII.12. Other
recombinants that were identified were GII.Pg/GII.1, GII.Pe/GII.4 Osaka 2007, GII.P4 New Orleans 2009/GII.4 Sydney
2012, GII.P7/GII.6. To date these recombinant types all have a reportedly restricted geographic distribution. This is
the first report of the GII.P4 New Orleans 2009/GII.4 Sydney 2012 recombinant in Africa.
Conclusions: Over the past four years, remarkably diverse NoV recombinants have been circulating in SA.
Pandemic strains such as the GII.Pe/GII.4 Sydney 2012 recombinant co-circulated with novel and emerging
recombinant strains. Combined polymerase- and capsid-based NoV genotyping is essential to determine the true
diversity and global prevalence of these viruses.
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Noroviruses (NoVs) are the leading cause of viral gastro-
enteritis worldwide. In recent years, the importance of
NoV recombinants as gastroenteritis pathogens has in-
creasingly been recognised. Norovirus has a single-
stranded positive sense RNA genome, ranging between
7.3 and 7.7 kb [1]. The genome is divided into three
open reading frames (ORFs), with ORF1 encoding a
large polyprotein which is processed into six non-
structural proteins. The major and minor capsid proteins
are encoded by ORFs 2 and 3, respectively. Noroviruses
are classified into 6 genogroups (G) of which GI, GII
and GIV infect humans [1]. Currently, based on complete* Correspondence: janet.mans@up.ac.za
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unless otherwise stated.capsid gene sequences, the genogroups are further divided
into nine GI, 22 GII and two GIV genotypes [1-3].
Routinely NoVs are genotyped by analysis of partial capsid
or polymerase gene sequences. However, genotyping based
solely on one region of the NoV genome is not a true rep-
resentation of the epidemiology of the virus due to fre-
quent recombination within NoVs [4]. Recombination
commonly occurs at the ORF1-ORF2 junction [4] al-
though other recombination sites have been reported
[5,6]. To address the inconsistencies in NoV genotyp-
ing, a new nomenclature system, which incorporates
both polymerase and capsid regions has recently been
proposed [7].
Several globally prevalent NoV strains have been char-
acterised as recombinants. The current predominant
GII.4 variant, Sydney 2012, is a recombinant between
GII.Pe in the polymerase and GII.4 in the capsid regiontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.virologyj.com/content/11/1/168[8]. Another GII.4 recombinant between the New Orleans
2009 polymerase and Sydney 2012 capsid regions is also
in circulation [9]. After GII.4, the GII.P21/GII.3 recom-
binant is the second most prevalent NoV strain detected
in children with gastroenteritis [10]. Other recently de-
scribed recombinants include the GII.Pg/GII.1 and GII.
Pg/GII.12 strains [11,12]. Since 2010, the GII.Pg/GII.1
recombinant has been associated with foodborne out-
breaks of gastroenteritis in Belgium and Germany
[11,13]. Norovirus recombinant GII.Pg/GII.12 emerged
in Australia in 2008 [14] and has since been reported in
the United States (US), where it was responsible for 16%
of gastroenteritis outbreaks in the 2009–2010 winter
season [12], and in children in Italy during the same
time period [15].
In South Africa (SA), NoV-associated gastroenteritis
outbreaks were first reported in 1993, where Norwalk
(GI.1) and Hawaii (GII.1) strains were each identified as
causative agents in outbreaks [16]. In 2008, NoVs were
characterised from paediatric patients hospitalised with
gastroenteritis in the Pretoria region of SA. Noroviruses
were detected in 14% of stool specimens and the charac-
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*Breakpoint position relative to the start of ORF2, NA – Not assigned, ND – Not det
(~1090 bp); bthe complete polymerase-capsid overlap region (~1820 bp); and cthewith GII.4 being predominant [17]. These genotypes
were determined based only on capsid gene sequences.
Increased awareness of the circulation and emergence of
NoV recombinants highlights the need to genotype
based on both polymerase and capsid gene regions. In
this study, the presence of known and novel recombin-
ant NoVs is reported for the first time in SA.
Results
From 2010 to 2013, eleven NoV recombinant types were
identified in SA (Table 1). Ten of these recombinants
were identified in children with NoV gastroenteritis and
one recombinant originated from an adult with sporadic
gastroenteritis. Phylogenetic analysis grouped the partial
polymerase and capsid regions of each strain into dif-
ferent genotypes, suggesting recombination (Figure 1A
and B). Subsequent maximum x2 and SimPlot analysis of
a 1090 bp region, spanning the polymerase and capsid
typing regions, indicated that all recombination break-
points (P < 0.05) were at the ORF1/2 junction (Table 1,
Figures 2 and 3). The majority were intergenotype recom-
binants and two GII.4 intragenotype recombinants were










6* 2.154 × 10−13 JX439787 (98%/99%)a China, India, Korea
ND KC597144 (89%/99%)b Novel polymerase
region
ND JX448566 (96%/99%)c Novel capsid
region
8 1.608 × 10−4 JN797508 (93%/99%)a Europe, US
7 1.610 × 10−15 JX683114 (93%/99%)a Novel recombinant
ND GQ845369 (97%/99%)c Australia, India,
Japan, US
14 1.846 × 10−13 AY682549 (96%/97%)a France
1 1.767 × 10−3 KF509947 (96%/99%)c Australia, Canada,
Europe, Asia, US
68 9.441 × 10−9 JQ613568 (98%/99%)a Asia, Australia,
Europe, US
20 8.515 × 10−15 KF145148 (98%/99%)c Worldwide
6 8.238 × 10−10 KJ407072 (96%/98%)a Japan, US
ermined, #Based on BLAST analysis of athe polymerase-capsid overlap region
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Figure 1 Nucleotide phylogenetic analysis of A) the partial polymerase gene and B) the partial capsid gene of recombinant noroviruses
(NoVs) detected in South Africa. Neighbor-joining phylogenetic analysis of the partial polymerase (720 bp) region and the partial capsid (270 bp)
region of 11 NoV recombinant strains. The NoV reference strains are indicated by GenBank accession numbers and the strains identified in this study
are shown in bold. Statistical significance was evaluated with a 1000 bootstrap replicates and bootstrap support of >70% is indicated. The scale bar
represents nucleotide substitutions per site.
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GII.3, GII.P4 New Orleans 2009/GII.4 NA and GII.P16/
GII.17, are reported for the first time. Phylogenetic
analysis of a 720 bp region of the polymerase gene of
Bushbuckridge 6387 (GII.P NA/GII.3) did not group
this strain with an established polymerase-based geno-
type, although the strain is most closely related to the
GII.Pg strains (Figure 1A). Following nucleotide sequence
determination of the complete polymerase gene it re-
mained unassigned (Figure 4A). The closest matches on
GenBank are GII.Pg/GII.3 (KC597144) and GII.Pa/GII.3
(JX846924) recombinants from China with which it shares
90% sequence identity. Cape Town 6745 is an intragen-
otype GII.4 recombinant with a New Orleans 2009 poly-
merase and an unassigned capsid region. The variant
could not be assigned using the nucleotide or amino acid
sequence of the complete capsid (Figure 4B and C). Thisstrain is related to the Apeldoorn 2007 variant and shares
96% nucleotide identity with five strains in GenBank. The
third novel recombinant is a combination of GII.P16 and
GII.17. The most closely related strain on GenBank, a GII.
P16/GII.3 recombinant detected in Bangladesh in 2012
(JX683114), is 93% identical to the SA strain.
Strains with the GII.P21 polymerase were found in
combination with GII.2 or GII.3 capsids, both of which
are widely reported recombinants. The GII.P21/GII.2
and the GII.P21/GII.3 SA strains share 96% (AY682549)
and 98% (JX439787) nucleotide identity with their respect-
ive closest matches from GenBank. The GII.Pg polymerase
genotype was identified as a recombinant with GII.1 or
GII.12 capsids. The GII.Pg polymerase sequences cluster in
two distinct groups within the GII.Pg genotype (Figure 1A),
with the GII.Pg/GII.1 sharing only 93% nucleotide se-
quence identity with the closest match in GenBank
Figure 2 Similarity plots of intergenotype NoV recombinants identified in South Africa. The similarity plots were created with the
polymerase/capsid sequence (1010–1090 bp) spanning the ORF1/ORF2 junction using SimPlot version 3.5.1, with a window size of 200 bp and an
increment of 20 bp. In each graph, the black and grey lines represent the percentage identity of the putative parental strains to each respective
recombinant. The start of ORF2 is indicated by the dashed red line (position 721 or 786). The predicted recombination breakpoint is where the
parental strains share equal identity to the recombinant strain.
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GII.6, was detected in Johannesburg in 2013. The most
closely related strain in GenBank is 96% identical over
98% of the polymerase/capsid overlap region and was
identified in the US in 2010 (KJ407072).
In addition to the novel GII.P4 New Orleans 2009/GII.4
NA recombinant, three other GII.4 recombinants were
identified. The currently globally predominant variant cap-
sid, Sydney 2012, was found in combination with both the
GII.Pe and GII.P4 New Orleans 2009 polymerase geno-
types. The GII.Pe/GII.4 Sydney 2012 SA strain is 98%
identical to strains circulating in Asia, Canada, Italy andAustralia. The GII.P4 New Orleans 2009/GII.4 Sydney
2012 recombinant is most closely related (96% nucleotide
sequence identity) to a strain from Canada (KF509947). A
non-epidemic GII.4 variant, the GII.Pe/GII.4 Osaka 2007
recombinant was also characterised.
Discussion
Combined characterisation of the polymerase and capsid
regions of NoVs has increased awareness and detection
of NoV recombinants worldwide. Consequently, it has
become clear that NoV genetic diversity is greatly en-
hanced by inter- and intragenotype recombination.
Figure 3 Similarity plots of NoV GII.4 recombinants identified in South Africa. The similarity plots were created with the polymerase/capsid
sequence (1088 bp) spanning the ORF1/ORF2 junction using SimPlot version 3.5.1, with a window size of 200 bp and an increment of 20 bp. In
each graph, the black and grey lines represent the percentage identity of the putative parental strains to each respective recombinant. The start
of ORF2 is indicated by the dashed red line (position 785 or 786). The predicted recombination breakpoint is where the parental strains share
equal identity to the recombinant strain.
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ing in individuals with gastroenteritis in SA. One novel
recombinant, Bushbuckridge 6387, with an unassigned
polymerase region combined with a GII.3 capsid, shares
88% nucleotide identity over the polymerase region with
two NoV strains that had circulated in Hong Kong,
China between December 1977 and January 1978. The
most recently described strain related to Bushbuckridge
6387 in the polymerase region is strain KC597145, a GII.
Pg/GII.12 recombinant detected in 2010 in the US (86%
nucleotide sequence identity). This reflects the evolu-
tionary relationship between the unassigned polymerase
and the GII.Pa and GII.Pg polymerases. The partial capsid
sequence of this recombinant is 98% identical to a NoV
GII.3 strain (AB385634) that was detected in 2005 in the
Netherlands. It appears that a polymerase genotype that
had been circulating undetected for many years has re-
combined with the prevalent GII.3 capsid genotype.
Another novel intergenotype recombinant detected in
this study was the GII.P16/GII.17 strain. The GII.P16
polymerase was recently described in combination with
the GII.2 capsid in China [18] and Japan [19] as well aswith the GII.3 capsid in Bangladesh [20] and Italy [21].
In addition a GII.P16/GII.13 recombinant was also de-
tected in children with gastroenteritis in Italy [21]. These
data suggest that the GII.P16 polymerase could be pre-
disposed to recombination. The GII.16 and GII.17 geno-
types (based on the partial capsid gene) have been
detected in SA in clinical specimens [17] and environ-
mental samples [22,23], respectively. Therefore mixed
infections with GII.P16/GII.16 and GII.P17/GII.17 could
have occurred providing the opportunity for recombin-
ation. Analysis of GII.P16 sequences available on Gen-
Bank revealed that this polymerase type is circulating in
Africa (KJ394506), Asia (KJ145841) and Central America
(KF177231) and that it has been detected on frozen
strawberries implicated in a gastroenteritis outbreak in
Germany (KC207117).
One of the most widely reported recombinant strains,
GII.P21/GII.3, was also identified in this study. The SA
strain is related to a subgroup of GII.P21/GII.3 recombi-
nants, which have been reported in China [18], India [5]
and Korea (JX439784-91). The GII.P21/GII.2 recombinant
was first reported in 2005 [24] and the ORF1/2 overlap
 JX459908 Sydney 2012
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Figure 4 (See legend on next page.)
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Figure 4 Phylogenetic analysis of unassigned norovirus (NoV) recombinants. Neighbor-joining phylogenetic analysis of A) the complete
polymerase gene (1533 bp) of Bushbuckridge 6387 (GII.P NA/GII.3), B) the complete capsid (1623 bp) gene of NoV GII.4 variants and, C) the 540
amino acid sequence encoded by the capsid gene of the NoV GII.4 variants. For the amino acid tree the evolutionary distances were computed
using the Poisson correction method and are in the units of the number of amino acid substitutions per site. The NoV reference strains are
indicated by GenBank accession numbers as well as GII.4 variant names and the strains identified in this study are shown in bold. Statistical
significance was evaluated with a 1000 bootstrap replicates and bootstrap support of >70% is indicated. The scale bar represents nucleotide or
amino acid substitutions per site.
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strain Pont de Roide 673/04/Fr. This intergenotype re-
combinant has not been reported as extensively. The GII.
Pg/GII.1 has only been reported in Europe [11,13] and the
US (JN797508). The SA recombinant is not closely related
(<93% nucleotide sequence identity) to any of the reported
strains, specifically in the polymerase region. GII.Pg/
GII.12 recombinants have been reported in Australia [14],
China [25], Europe [15,26] and the US [12,27]. To date
this is the first report of these recombinant types circulat-
ing in Africa.
One recombinant type recently described for the first
time in Burkina Faso, GII.P7/GII.6, was also detected.
The SA strain shares 94% identity over 98% of the nu-
cleotide sequence from Burkina Faso [28], with only 92%
nucleotide identity in the capsid region. The capsid re-
gion of the SA recombinant is most closely related (97%
identity over 92% of Region C) to a Japanese GII.6 strain
(AB919088) reported in Okinawa in 2014. This indicates
that two lineages of GII.P7/GII.6 recombinants may be
circulating in Africa. The closest match to the SA strain
was a GII.P7/GII.6 from the US (KJ407072), with which
it shares 96% nucleotide identity over 98% of the se-
quenced region. GII.P7/GII.6 recombinants have also been
reported in Finland [26], Japan (AB818397-400) and
Sweden (KF768487), although the strains from Finland re-
main unconfirmed.
Inter- and intragenotype GII.4 recombinants have
been identified in SA. The GII.Pe/GII.4 Osaka 2007 vari-
ant, considered a non-epidemic variant, was detected in
2011. The SA variant is closely related (97% identity over
99% of the overlap region) to the original strain de-
scribed in Japan in October 2007 (AB434770). Based on
BLAST analysis, the SA GII.Pe/GII.4 Sydney 2012 re-
combinant is closely related to strains circulating on sev-
eral continents [8,29-31]. This is the first report of the
globally dominant GII.Pe/GII.4 Sydney 2012 variant on
the African continent. A GII.Pe/GII.4 recombinant has
been reported from Burkina Faso [28] but the GII.4 vari-
ant is unassigned. Within the GII.4 lineage, recombin-
ation has been described between ORF1/2, ORF2/3 and
within ORF2 [6]. In this study both intra- GII.4 recombi-
nants had breakpoints at the ORF1/2 junction. The GII.
P4 New Orleans 2009/GII.4 Sydney 2012 recombinant is
less prevalent than the GII.Pe/GII.4 Sydney 2012 variant,with reports from Canada [32], Denmark [9] and Italy
[33]. The presence of another intragenotype GII.4 re-
combinant in SA illustrates the remarkable diversity
generated by recombination within the GII.4 genotype.
The prevalent New Orleans 2009 polymerase appears to
have recombined with an unassigned GII.4 capsid from
the Apeldoorn 2007 lineage related to capsid genotypes
which circulated in SA in 2008 [17]. In theory, the possi-
bility cannot be excluded that these GII.4 intragenotype
recombinants are the result of divergent evolution of the
Apeldoorn 2007 lineage in the capsid gene. However, Eden
and colleagues [6] have provided compelling evidence that
recombination played an important role in the evolution
of several recent GII.4 pandemic variants leading to an in-
crease in the genetic repertoire of the major GII.4 lineage.
Conclusions
Recombination contributes significantly to create diversity
within NoVs. This study has revealed the presence of novel,
emerging and widely reported recombinants in SA. The
data presented here highlights the importance of combined
polymerase- and capsid-based NoV genotyping to allow
meaningful global epidemiological comparison of NoVs.
Methods
Specimen collection and preparation
From 2010 to 2012, NoV GII-positive stool specimens
were selected for further genotypic characterisation. All
specimens were received from the Rotavirus Sentinel Sur-
veillance Programme which routinely screens stool speci-
mens for enteric pathogens. Specimens were received
from children up to the age of 5 years who were hospita-
lised with severe gastroenteritis in four provinces of SA:
Gauteng (Johannesburg), KwaZulu-Natal (Empangeni and
Pietermaritzburg), Mpumalanga (Bushbuckridge) and the
Western Cape (Cape Town). In 2013, a NoV GII-positive
stool specimen from a sporadic case of gastroenteritis in
an adult was also characterised. Stool suspensions (10%)
were prepared in ultrapure water (Adcock Ingram,
Johannesburg, SA) and stored at −20°C until nucleic
acid extraction.
Nucleic acid extraction
For amplification of partial RNA polymerase (region A)
and capsid (region C) gene regions, nucleic acid was
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MagNA Pure LC Total Nucleic Acid Isolation kit (Roche
Diagnostics GmbH, Mannheim, Germany) on the auto-
mated MagNA Pure system (Roche Diagnostics). For
amplification of a region spanning partial polymerase
and capsid genes, nucleic acid was extracted from 140 μl
stool suspension using the QIAamp Viral RNA Mini kit
(Qiagen, Hilden, Germany). Nucleic acid was eluted in
50–60 μl and stored at −70°C until use.
Genotyping of noroviruses – amplification and
sequencing
Reverse transcription was performed using 10 μl ex-
tracted RNA and 50 U RevertAid™ Premium reverse
transcriptase (Thermo Scientific, Waltham, MA), with
30 μM random hexamer primers. Region A (polymerase
gene) was amplified using 5 μl of cDNA in a 50 μl reac-
tion containing 200 μM dNTPs, 0.3 μM primers JV12Y
and JV13I [34], 1.25 U AmpliTaq Gold DNA polymerase
(Applied Biosystems, Foster City, CA) and 1.5 mM
MgCl2. The reaction conditions were as follows: 95°C
for 10 min, 40 cycles of 95°C for 30 sec, 37°C for 1 min
30 sec, 72°C for 1 min and a final step at 72°C for 5 min.
Region C (capsid gene) was amplified using published
primers G2SKF and G2SKR [35] as previously described
[22]. The overlap region (1090 bp), spanning sections of
the polymerase and capsid genes including the suspected
recombination breakpoint, was amplified using primers
JV12Y and G2SKR. Briefly, the 50 μl reaction contained
0.5 μl cDNA, 1.25 U AmpliTaq Gold DNA polymerase
(Applied Biosystems), 200 μM dNTPs, 0.3 μM primer
JV12Y and 1 μM primer G2SKR, using the following
cycling parameters: 95°C for 10 min, 40 cycles of 94°C
for 30 sec, 37°C for 1 min and 72°C for 2 min, followed
by 72°C for 5 min. For strains that could not be geno-
typed based on partial polymerase or capsid sequences
(remained unassigned phylogenetically), complete poly-
merase or capsid genes were amplified, respectively. For
amplification of the complete polymerase gene, the fol-
lowing primer was designed: GIIpolF 5′-GTC ATC TGT
GCA ACA CAA GG-3′ and used in conjunction with
JV13I to amplify a 1038 bp region of ORF1. The 50 μl
reaction contained 1.25 U AmpliTaq Gold DNA poly-
merase, 200 μM dNTPs, 0.5 μM of GIIpolF and 0.3 μM
JV13I. The following cycling parameters were used: 95°C
for 10 min, followed by 40 cycles of 95°C for 30 sec, 37°C
for 1 min 30 sec and 72°C for 2 min, and a final extension
at 72°C for 5 min. A consensus sequence was created
using this amplicon and the overlap amplicon to obtain
the complete RNA polymerase gene (1533 bp). A two-step
semi-nested RT-PCR was used to amplify the 1623 bp cap-
sid gene. In the first reaction, 1 μl of cDNA was combined
with 1.25 U AmpliTaq Gold DNA polymerase, 200 μM
dNTPs, primers QNIF2 [36] (200 nM) and GII.4 capsidreverse (5′-CCA TTA TAA WRC WCG YCT RCG CC-
3′) (600 nM) and PCR buffer containing 1.5 mM MgCl2.
One microliter of the first round PCR product was used as
template in the second PCR, which used the same reaction
mix except for forward primer G2SKF. The following cyc-
ling parameters were used: 95°C for 10 min, 35 cycles of
94°C for 45 sec, 58°C for 1 min and 72°C for 1 min 40 sec,
and a final extension at 72°C for 10 min. All primers were
manufactured by Applied Biosystems.
Amplicons from the partial RNA polymerase and capsid
gene regions were sequenced directly with the ABI PRISM
BigDye® Terminator v.3.1 Cycle Sequencing kit (Applied
Biosystems) on an ABI 3130 automated analyser (Applied
Biosystems). The overlap amplicon, partial ORF1 and
complete capsid amplicons were cloned before sequencing,
using the CloneJET™ PCR cloning kit (Thermo Scientific).
At least two randomly selected clones were sequenced
using pJET1.2/blunt specific primers (Thermo Scientific).
Genotyping of noroviruses – phylogenetic analysis
Nucleotide sequences were edited and analysed using
Sequencher™ 4.9 (Gene Codes Corporation, Ann Arbor,
MI), BioEdit Sequence Alignment Editor (V.7.0.9.0) [37]
and BLAST-n [38]. The polymerase and capsid genotypes
were determined using the Norovirus Genotyping Tool [2]
as well as phylogenetic analysis performed in MEGA6
[39]. Sequences were aligned with reference strains using
MAFFT version 6 (http://mafft.cbrc.jp/alignment/server/
index.html) and phylogenetic analysis was performed
using the neighbor-joining method, validated by 1000
bootstrap replicates. Genotypes were assigned based on
clustering with reference strains in the phylogenetic tree
with >70% bootstrap support.
Genotyping of noroviruses – analysis of recombination
Selected NoV strains that clustered with different geno-
types based on phylogenetic analysis of the polymerase
and capsid sequences were subjected to further recombin-
ation analysis. Putative recombination breakpoint analysis
was performed using SimPlot version 3.5.1 and the max-
imum x2 test as implemented in RDP version 4.33 [40].
Nucleotide sequence accession numbers
Sequences were submitted to GenBank under the fol-
lowing accession numbers: KC962457-62; KJ710245-48;
KM025143.
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